Yu Gu

PACIFIC-2: Phase 3 study of concurrent durvalumab and platinum-based chemoradiotherapy in patients with unresectable, stage III NSCLC.

Jeffrey D. Bradley, Makoto Nishio, Isamu Okamoto et al. · Journal of Clinical Oncology · 2019 · 61 citations

Immunology, Concurrent Durvalumab, Pharmacotherapy +21

SentiPrompt: Sentiment Knowledge Enhanced Prompt-Tuning for Aspect-Based Sentiment Analysis

Chengxi Li, Feiyu Gao, Jiajun Bu et al. · arXiv (Cornell University) · 2021 · 57 citations · Full text

Triplet Extraction, Engineering, Multimodal Sentiment Analysis +17

A Randomized, Open-Label Phase II Trial of Volasertib as Monotherapy and in Combination With Standard-Dose Pemetrexed Compared With Pemetrexed Monotherapy in Second-Line Treatment for Non–Small-Cell Lung Cancer

Peter Ellis, Natasha B. Leighl, Vera Hirsh et al. · Clinical Lung Cancer · 2015 · 56 citations

Second-line Treatment, Medicine, Pemetrexed Monotherapy +9

Rheinic acid ameliorates radiation-induced acute enteritis in rats through PPAR-γ/NF-κB

Haixia Sha, Yu Gu, Weixing Shen et al. · Genes & Genomics · 2019 · 25 citations

Inflammation, Anti-inflammatory, Rheinic Acid +6

Dual drug-loaded PLA nanoparticles bypassing drug resistance for improved leukemia therapy

Liuliu Zhang, Huayun Zhu, Yu Gu et al. · Journal of Nanoparticle Research · 2019 · 20 citations · Full text

Nanoparticles, Nanotherapeutics, Engineering +16